Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Postgrad Med. 2005 Apr;117(4):29-30, 33-5, 39 passim.

Taking aim at HDL-C. Raising levels to reduce cardiovascular risk.

Author information

  • Kos Pharmaceuticals.

Abstract

Although statin therapy has revolutionized management of coronary heart disease (CHD), the lowering of low-density lipoprotein cholesterol (LDL-C) levels is not the whole story. Increased plasma concentrations of high-density lipoprotein cholesterol (HDL-C) have a cardioprotective effect that is just as important for reducing risk of heart attack and stroke. In this article, Dr McGovern examines the evidence that provides the rationale for HDL-C as a therapeutic target for cardiovascular risk reduction.

Comment in

PMID:
15842130
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk